The effect of the α-emitting radionuclide lead-212 on human ovarian carcinoma: A potential new form of therapy

Jacob Rotmensch; Robert W. Atcher; Robert Schlenker; John Hines; David Grdina; Barry S. Block; Michael F. Press; Arthur L. Herbst; Ralph R. Weichselbaum

doi:10.1016/S0090-8258(89)80040-X

The effect of the α-emitting radionuclide lead-212 on human ovarian carcinoma: A potential new form of therapy

Jacob Rotmensch, Robert W. Atcher, Robert Schlenker, John Hines, David Grdina, Barry S. Block, Michael F. Press, Arthur L. Herbst, Ralph R. Weichselbaum

Gynecology and Obstetrics

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	236-239
Number of pages	4
Journal	Gynecologic Oncology
Volume	32
Issue number	2
DOIs	https://doi.org/10.1016/S0090-8258(89)80040-X
State	Published - Feb 1989

ASJC Scopus Subject Areas

Oncology
Obstetrics and Gynecology

Access to Document

10.1016/S0090-8258(89)80040-X

OpenUrl availability

Full text

Cite this

@article{fcf7145bbde94e7ebfc667adcddc05f3,

title = "The effect of the α-emitting radionuclide lead-212 on human ovarian carcinoma: A potential new form of therapy",

author = "Jacob Rotmensch and Atcher, {Robert W.} and Robert Schlenker and John Hines and David Grdina and Block, {Barry S.} and Press, {Michael F.} and Herbst, {Arthur L.} and Weichselbaum, {Ralph R.}",

note = "Funding Information: This work was supported in part by CA-27476, ACS Institutional Funds, NIH 5 RO1 CA-37436, and Office of Health and Environmental Research, U.S. Department of Energy, and the Cancer Research Foundation.",

year = "1989",

month = feb,

doi = "10.1016/S0090-8258(89)80040-X",

language = "English",

volume = "32",

pages = "236--239",

journal = "Gynecologic Oncology",

issn = "0090-8258",

number = "2",

}

TY - JOUR

T1 - The effect of the α-emitting radionuclide lead-212 on human ovarian carcinoma

T2 - A potential new form of therapy

AU - Rotmensch, Jacob

AU - Atcher, Robert W.

AU - Schlenker, Robert

AU - Hines, John

AU - Grdina, David

AU - Block, Barry S.

AU - Press, Michael F.

AU - Herbst, Arthur L.

AU - Weichselbaum, Ralph R.

N1 - Funding Information: This work was supported in part by CA-27476, ACS Institutional Funds, NIH 5 RO1 CA-37436, and Office of Health and Environmental Research, U.S. Department of Energy, and the Cancer Research Foundation.

PY - 1989/2

Y1 - 1989/2

UR - http://www.scopus.com/inward/record.url?scp=0024599993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024599993&partnerID=8YFLogxK

U2 - 10.1016/S0090-8258(89)80040-X

DO - 10.1016/S0090-8258(89)80040-X

M3 - Article

C2 - 2910786

AN - SCOPUS:0024599993

SN - 0090-8258

VL - 32

SP - 236

EP - 239

JO - Gynecologic Oncology

JF - Gynecologic Oncology

IS - 2

ER -

The effect of the α-emitting radionuclide lead-212 on human ovarian carcinoma: A potential new form of therapy

ASJC Scopus Subject Areas

Access to Document

OpenUrl availability

Other files and links

Cite this